Assessment of sorafenib induced changes in tumor perfusion of uveal melanoma metastases with dynamic contrast-enhanced ultrasound (DCE-US)

PURPOSE: Dynamic contrast-enhanced ultrasound (DCE-US) was used to monitor early response to sorafenib therapy in patients with liver metastases from uveal melanoma. METHODS: In total, 21 patients with liver metastases were recruited within a prospective trial and underwent daily sorafenib therapy....

Descripción completa

Detalles Bibliográficos
Autores principales: Wildner, Dane, Heinzerling, Lucie, Scheulen, Max E., Kaempgen, Eckhart, Schuler, Gerold, Strobel, Deike, Janka, Rolf, Neurath, Markus F., Sturm, Joerg, Knieling, Ferdinand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article – Clinical Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930795/
https://www.ncbi.nlm.nih.gov/pubmed/34050396
http://dx.doi.org/10.1007/s00432-021-03666-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930795/
https://www.ncbi.nlm.nih.gov/pubmed/34050396
http://dx.doi.org/10.1007/s00432-021-03666-8

Ejemplares similares